Companhia Siderúrgica Nacional (BCBA:CSNA3)
| Market Cap | 2.47T -2.2% |
| Revenue (ttm) | 11.78T -0.9% |
| Net Income | -529.32B |
| EPS | -399.16 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,256 |
| Average Volume | 1,474 |
| Open | 1,905.00 |
| Previous Close | 1,808.00 |
| Day's Range | 1,890.00 - 1,950.00 |
| 52-Week Range | 1,548.00 - 3,307.50 |
| Beta | n/a |
| RSI | 51.88 |
| Earnings Date | May 13, 2026 |
About BCBA:CSNA3
Companhia Siderúrgica Nacional, together with its subsidiaries, operates as an integrated steel producer in Brazil and internationally. It operates through five segments: Steel Industry, Mining, Logistics, Energy, and Cement. The Steel Segment offers produce and sells of flat and long steel. The Mining Segment engages in extraction, processing and marketing of iron ore, tin, limestone, and dolomite. The Logistics Segment supplies railways, port concessions, and road fleet. The Cement Segment produces and sells bagged and bulk cement, as well as... [Read more]
Financial Performance
In 2025, BCBA:CSNA3's revenue was 44.80 billion, an increase of 2.54% compared to the previous year's 43.69 billion. Losses were -2.00 billion, -22.74% less than in 2024.
Financial numbers in BRL Financial StatementsNews
National Steel Q1 Earnings Call Highlights
National Steel NYSE: SID, the Brazilian steelmaker known as CSN, reported higher first-quarter 2026 adjusted EBITDA despite heavy rainfall, a stronger Brazilian real and continued pressure from steel ...
National Steel Q1 Earnings Call Highlights
National Steel (NYSE:SID), the Brazilian steelmaker known as CSN, reported higher first-quarter 2026 adjusted EBITDA despite heavy rainfall, a stronger Brazilian real and continued pressure from steel...
Companhia Siderurgica Nacional (SID) Q1 2026 Earnings Call Highlights: Record Iron Ore ...
Companhia Siderurgica Nacional (SID) Q1 2026 Earnings Call Highlights: Record Iron Ore Shipments and Strategic Debt Management
Companhia Siderúrgica Nacional Earnings Call Transcript: Q1 2026
Q1 2026 saw 5.5% EBITDA growth year-over-year, driven by strong cement and logistics performance, reduced leverage, and record mining output despite heavy rainfall. Asset sales and deleveraging are progressing, with robust demand and pricing in key segments.
Companhia Siderúrgica Nacional Earnings Call Transcript: Q1 2026
EBITDA grew 5.5% year-over-year in Q1 2026, driven by strong cement and logistics performance despite adverse weather and import competition. Leverage improved to 3.36×, asset sales are progressing, and favorable trends are expected in steel and cement for the rest of the year.
Companhia Siderúrgica Nacional Earnings release: Q1 2026
Companhia Siderúrgica Nacional released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
Companhia Siderúrgica Nacional Slides: Q1 2026
Companhia Siderúrgica Nacional has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.
Companhia Siderúrgica Nacional Earnings release: Q1 2026
Companhia Siderúrgica Nacional released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
Companhia Siderúrgica Nacional Slides: Q1 2026
Companhia Siderúrgica Nacional has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg cells and influence multiple inflammatory pathways. Data supports potential fo...
TRexBio to Present Late-Breaking Data at the Society for Investigative Dermatology (SID) Annual Meeting Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DeepBiology--TRexBio to Present Late-Breaking Data at SID 2026 Supporting TNFR2 Agonism as a Therapeutic Strategy for Atopic Dermatitis.
Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investigative Dermatology (SID) Annual Meeting
Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcinoma Tumors WEST CHESTER, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verric...
See How Companhia Siderurgica Nacional Ranks Among Analysts' Top Metals Picks
A study of analyst recommendations at the major brokerages shows that Companhia Siderurgica Nacional (Symbol: SID) is the #31 broker analyst pick, on average, out of the 50 stocks making up the Metals...
CSN announces its Annual Report on Form 20-F for the fiscal year ended December 31, 2025
SÃO PAULO, April 30, 2026 /PRNewswire/ -- Companhia Siderúrgica Nacional (NYSE: SID and B3: CSNA3) ("CSN") has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025 with the...
Shares of SID Now Oversold
In trading on Thursday, shares of Companhia Siderurgica Nacional (Symbol: SID) entered into oversold territory, changing hands as low as $1.19 per share. We define oversold territory using the Relativ...
Companhia Siderurgica Nacional (SID) Q4 2025 Earnings Call Highlights: Record EBITDA Growth ...
Companhia Siderurgica Nacional (SID) Q4 2025 Earnings Call Highlights: Record EBITDA Growth Amid Strategic Investments
Companhia Siderúrgica Nacional Earnings Call Transcript: Q4 2025
Record 2025 results driven by mining, logistics, and cost reductions, with EBITDA up 15% year-over-year. Strategic asset sales and anti-dumping measures aim to reduce leverage and support margin recovery in 2026.
Companhia Siderúrgica Nacional Earnings Call Transcript: Q4 2025
Record 2025 results driven by mining, logistics, and cost reductions, with EBITDA up 15% year-over-year. Strategic asset sales and anti-dumping measures aim to reduce leverage and support margin recovery in 2026.
Companhia Siderúrgica Nacional Earnings release: Q4 2025
Companhia Siderúrgica Nacional released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
Companhia Siderúrgica Nacional Slides: Q4 2025
Companhia Siderúrgica Nacional has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.
Companhia Siderúrgica Nacional Annual report: Q4 2025
Companhia Siderúrgica Nacional has published its Q4 2025 annual report on March 12, 2026.
Companhia Siderúrgica Nacional Annual report: Q4 2025
Companhia Siderúrgica Nacional has published its Q4 2025 annual report on March 12, 2026.
Companhia Siderúrgica Nacional Earnings release: Q4 2025
Companhia Siderúrgica Nacional released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
Companhia Siderúrgica Nacional Slides: Q4 2025
Companhia Siderúrgica Nacional has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.
Companhia Siderúrgica Nacional Annual report: Q4 2025
Companhia Siderúrgica Nacional has published its Q4 2025 annual report on March 12, 2026.